Y Combinator backs ChatGPT dog cancer vaccine — for humans
yc-backed startup gamgee launches to scale personalized mrna cancer vaccines designed via chatgpt, targeting pets and eventually humans despite lacking verified clinical data.
gamgee, a new startup backed by y combinator, aims to produce personalized mrna cancer vaccines designed with ai tools like chatgpt and grok, initially targeting dogs before expanding to human medicine. founder paul conyngham claims the technology successfully treated his dog, citing a roughly 75% tumor reduction and proposing a four-week turnaround time for veterinarians. however, experts question the scientific validity, noting the ai's role appears exaggerated and the outcomes cannot be distinguished from other simultaneous treatments. the company is recruiting clinical trials in australia and accepting global cases, attempting to scale a bio-intervention currently based on anecdotal evidence.